Scarica l'app Stockscreener
3.41
25.83%
0.70
Dopo l'orario di chiusura:
3.28
-0.13
-3.81%
Precedente Chiudi:
$2.71
Aprire:
$2.96
Volume 24 ore:
20.35M
Relative Volume:
7.70
Capitalizzazione di mercato:
$12.96M
Reddito:
$9.37M
Utile/perdita netta:
$-8.45M
Rapporto P/E:
-4.2099
EPS:
-0.81
Flusso di cassa netto:
$-7.27M
1 W Prestazione:
+17.59%
1M Prestazione:
-56.45%
6M Prestazione:
-75.80%
1 anno Prestazione:
-94.79%
Intervallo 1D:
$2.86
$3.50
Intervallo di 1 settimana:
$2.55
$3.50
Portata 52W:
$2.3401
$67.12
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Nome
Bioaffinity Technologies Inc
Settore
Industria
Telefono
210-698-5334
Indirizzo
3300 NACOGDOCHES ROAD, SAN ANTONIO
Confronta BIAF con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
3.41 | 12.96M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
536.78 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
210.92 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
637.34 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.10 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.75 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie
BioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer - MarketScreener
bioAffinity stock soars after receiving patent allowance for AI lung cancer test - Investing.com
bioAffinity Technologies Secures Patent for Lung Cancer Detection - TipRanks
bioAffinity Technologies Announces U.S. Patent Allowance for Lung Cancer Detection Method - TradingView
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer - Yahoo Finance
BIAF announces USPTO notice of allowance for sputum-based test patent - Stock Titan
bioAffinity Technologies regains Nasdaq compliance By Investing.com - Investing.com Nigeria
How to interpret RSI for bioAffinity Technologies Inc. stockTrade Risk Summary & Weekly High Potential Stock Alerts - newser.com
Has bioAffinity Technologies Inc. Equity Warrant found a price floorJuly 2025 Retail & AI Enhanced Trade Execution Alerts - newser.com
Can trapped investors hope for a rebound in bioAffinity Technologies Inc. Equity WarrantBreakout Watch & Safe Capital Investment Plans - newser.com
Is it time to cut losses on bioAffinity Technologies Inc.July 2025 Outlook & Consistent Profit Alerts - newser.com
Intraday pattern recognizer results for bioAffinity Technologies Inc. Equity Warrant2025 Market Trends & Community Supported Trade Ideas - newser.com
Is bioAffinity Technologies Inc. Equity Warrant stock a good choice for value investors2025 Risk Factors & AI Based Buy and Sell Signals - newser.com
Will bioAffinity Technologies Inc. Equity Warrant benefit from macro trends2025 Key Lessons & Smart Money Movement Tracker - newser.com
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - PharmiWeb.com
Will bioAffinity Technologies Inc. Equity Warrant stock remain a Wall Street favorite2025 Investor Takeaways & Verified Trade Idea Suggestions - newser.com
Will bioAffinity Technologies Inc. stock deliver better than expected guidanceAnalyst Upgrade & Stock Market Timing Techniques - newser.com
bioAffinity Regains Nasdaq Compliance, Ensures Continued Trading - TipRanks
bioAffinity Technologies Regains Nasdaq Compliance - TradingView
BIAF back in compliance with Nasdaq bid price and equity rules - Stock Titan
bioAffinity Technologies regains Nasdaq compliance - Investing.com
bioAffinity Technologies Completes $4.8M Stock Offering - MSN
What recovery options are there for bioAffinity Technologies Inc.Day Trade & Smart Allocation Stock Tips - newser.com
Forecasting bioAffinity Technologies Inc. Equity Warrant price range with options dataJuly 2025 Movers & Smart Allocation Stock Reports - newser.com
Detecting price anomalies in bioAffinity Technologies Inc. Equity Warrant with AI2025 EndofYear Setup & Verified Trade Idea Suggestions - newser.com
bioAffinity Technologies Appoints New Board Members - MSN
How institutional buying supports bioAffinity Technologies Inc. Equity Warrant stockWeekly Loss Report & Safe Capital Growth Tips - newser.com
Can trapped investors hope for a rebound in bioAffinity Technologies Inc.CPI Data & Daily Profit Maximizing Tips - newser.com
BioAffinity Technologies announces $1.8M registered direct offering - MSN
Will bioAffinity Technologies Inc. Equity Warrant stock beat EPS estimatesMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
Why bioAffinity Technologies Inc. stock is in analyst buy zoneWall Street Watch & Low Drawdown Trading Strategies - newser.com
bioAffinity Technologies, Inc.Warrant (NQ: BIAFW - FinancialContent
Using data filters to optimize entry into bioAffinity Technologies Inc. Equity WarrantJuly 2025 PreEarnings & Fast Gaining Stock Reports - newser.com
Will bioAffinity Technologies Inc. stock see insider buying2025 Market Sentiment & Free Community Supported Trade Ideas - newser.com
Will bioAffinity Technologies Inc. stock maintain momentum in 2025Weekly Trend Report & Low Drawdown Investment Strategies - newser.com
Bioaffinity Technologies Inc Azioni (BIAF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):